Ypsomed Holding AG (SWX:YPSN)
Switzerland · Delayed Price · Currency is CHF 321.00
-0.50 (-0.16%)
At close: Dec 5, 2025
Ypsomed Holding AG Revenue
Ypsomed Holding AG had revenue of 362.69M CHF in the half year ending September 30, 2025, with 42.01% growth. This brings the company's revenue in the last twelve months to 787.55M, up 27.63% year-over-year. In the fiscal year ending March 31, 2025, Ypsomed Holding AG had annual revenue of 748.87M with 36.54% growth.
Revenue (ttm)
787.55M
Revenue Growth
+27.63%
P/S Ratio
5.56
Revenue / Employee
393.77K
Employees
2,644
Market Cap
4.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 748.87M | 200.41M | 36.54% |
| Mar 31, 2024 | 548.46M | 51.00M | 10.25% |
| Mar 31, 2023 | 497.46M | 32.62M | 7.02% |
| Mar 31, 2022 | 464.84M | 61.19M | 15.16% |
| Mar 31, 2021 | 403.66M | 9.39M | 2.38% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 44.95B |
| Sandoz Group AG | 8.42B |
| Alcon | 8.12B |
| Lonza Group AG | 7.09B |
| Galenica AG | 4.03B |
| Sonova Holding AG | 3.85B |
| Galderma Group AG | 3.73B |
Ypsomed Holding AG News
- 23 days ago - Ypsomed Holding AG (YPHDF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Ypsomed Holding AG 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 23 days ago - Ypsomed Holding AG (XSWX:YPSN) (H1 2026) Earnings Call Highlights: Strong Growth in Delivery ... - GuruFocus
- 23 days ago - Half Year 2026 Ypsomed Holding AG Earnings Call Transcript - GuruFocus
- 2 months ago - Ypsomed To Establish Production Plant In US With CHF 200 Mln First Phase Investment - Nasdaq
- 2 months ago - Ypsomed Holding AG (YPHDF) Analyst/Investor Day - Slideshow - Seeking Alpha
- 1 year ago - Novo Nordisk (NVO) Partners with Ypsomed for Next-Gen Obesity Drug Delivery - GuruFocus
- 1 year ago - Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens - Seeking Alpha